Informations sur le produit
- 4H-1-Benzopyran-2-carboxylicacid,7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-(9CI)
- 4H-1-Benzopyran-2-carboxylic acid, 7-[[9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-,[S-[R*,S*-(E,Z)]]-
Iralukast is a leukotriene receptor antagonist that blocks the bronchoconstrictor response. It is used in the treatment of bronchial asthma, chronic obstructive pulmonary disease, and bowel diseases such as ulcerative colitis. Iralukast is not absorbed into the bloodstream and therefore does not inhibit the production of the inflammatory mediators that are responsible for these diseases. Iralukast binds to receptors on cells lining the airways, preventing activation of cells by leukotrienes, which are released by mast cells in response to an allergen or irritant. This binding prevents the release of inflammatory mediators from mast cells and reduces bronchial reactivity. Iralukast also has been shown to inhibit the enzyme activity of phospholipase A2 (PLA2), which has been implicated in inflammatory bowel disease.
Propriétés chimiques
Question d’ordre technique sur : 3D-FA104085 Iralukast
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
